Trials / Completed
CompletedNCT04173104
PET and MRI Imaging of Brain Tumors Using [18F]PARPi
Pilot Study of [18F]PARPi PET/MR Imaging in Patients With New and/or Suspected Recurrent Brain Tumors
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to collect data about how 18FPARPi can be used together with PET/positron emission tomography and MRI/magnetic resonance imaging scans to take pictures of brain cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | PET/MR with [18F]PARPi | One PET/MR study (with up to 3 scan times) with \[18F\]PARPi |
| DRUG | [18F]PARPi | Injection of \<100ug of \[18F\]PARPi prior to 1 PET/MR |
Timeline
- Start date
- 2019-11-01
- Primary completion
- 2026-02-05
- Completion
- 2026-02-05
- First posted
- 2019-11-21
- Last updated
- 2026-02-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04173104. Inclusion in this directory is not an endorsement.